Literature DB >> 30354821

The Meaning of Mas.

Michael Bader1,2,3,4,5, Natalia Alenina1,3, Dallan Young6, Robson A S Santos7, Rhian M Touyz8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30354821      PMCID： PMC6217935          DOI： 10.1161/HYPERTENSIONAHA.118.10918

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  53 in total

1.  Multiple non-coding exons and alternative splicing in the mouse Mas protooncogene.

Authors:  Natalia Alenina; Ilka Böhme; Michael Bader; Thomas Walther
Journal:  Gene       Date:  2015-05-21       Impact factor: 3.688

2.  The imprinted antisense RNA at the Igf2r locus overlaps but does not imprint Mas1.

Authors:  R Lyle; D Watanabe; D te Vruchte; W Lerchner; O W Smrzka; A Wutz; J Schageman; L Hahner; C Davies; D P Barlow
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

3.  Characterization of an activated human ros gene.

Authors:  C Birchmeier; D Birnbaum; G Waitches; O Fasano; M Wigler
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

4.  Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains.

Authors:  D Young; G Waitches; C Birchmeier; O Fasano; M Wigler
Journal:  Cell       Date:  1986-06-06       Impact factor: 41.582

5.  Changes in inositol lipids and phosphates after stimulation of the MAS-transfected NG115-401L-C3 cell line by mitogenic and non-mitogenic stimuli.

Authors:  D R Poyner; P T Hawkins; H P Benton; M R Hanley
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

6.  G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor.

Authors:  Evi Kostenis; Graeme Milligan; Arthur Christopoulos; Carlos F Sanchez-Ferrer; Silvia Heringer-Walther; Patrick M Sexton; Florian Gembardt; Elaine Kellett; Lene Martini; Patrick Vanderheyden; Heinz-Peter Schultheiss; Thomas Walther
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

7.  The mouse insulin-like growth factor type-2 receptor is imprinted and closely linked to the Tme locus.

Authors:  D P Barlow; R Stöger; B G Herrmann; K Saito; N Schweifer
Journal:  Nature       Date:  1991-01-03       Impact factor: 49.962

8.  Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors.

Authors:  R A Santos; M J Campagnole-Santos; N C Baracho; M A Fontes; L C Silva; L A Neves; D R Oliveira; S M Caligiorne; A R Rodrigues; C Gropen Júnior
Journal:  Brain Res Bull       Date:  1994       Impact factor: 4.077

Review 9.  The renin-angiotensin system and malignancy.

Authors:  Eleanor I Ager; Jaclyn Neo; Christopher Christophi
Journal:  Carcinogenesis       Date:  2008-07-16       Impact factor: 4.944

10.  Atypical signaling and functional desensitization response of MAS receptor to peptide ligands.

Authors:  Kalyan C Tirupula; Russell Desnoyer; Robert C Speth; Sadashiva S Karnik
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240
View more
  17 in total

Review 1.  The renin-angiotensin system and cardiovascular autonomic control in aging.

Authors:  Amanda J Miller; Amy C Arnold
Journal:  Peptides       Date:  2021-12-29       Impact factor: 3.750

2.  Evaluation of the cardioprotective and antihypertensive effect of AVE 0991 in normotensive and hypertensive rats.

Authors:  Matheus Vinicius Barbosa da Silva; Célio Pereira de Sousa Júnior; Heverton Valentim Colaço da Silva; Vanessa Maria Dos Santos; Francisco Israel Magalhães Feijao; Amanda de Oliveira Bernardino; José Augusto Calafell Roig Tiburcio de Melo
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-07       Impact factor: 1.712

Review 3.  Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure.

Authors:  Lauren B Arendse; A H Jan Danser; Marko Poglitsch; Rhian M Touyz; John C Burnett; Catherine Llorens-Cortes; Mario R Ehlers; Edward D Sturrock
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

4.  SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes.

Authors:  Alexander G Obukhov; Bruce R Stevens; Ram Prasad; Sergio Li Calzi; Michael E Boulton; Mohan K Raizada; Gavin Y Oudit; Maria B Grant
Journal:  Diabetes       Date:  2020-07-15       Impact factor: 9.461

Review 5.  The Counter Regulatory Axis of the Lung Renin-Angiotensin System in Severe COVID-19: Physiopathology and Clinical Implications.

Authors:  Filippos Triposkiadis; Randall C Starling; Andrew Xanthopoulos; Javed Butler; Harisios Boudoulas
Journal:  Heart Lung Circ       Date:  2020-12-09       Impact factor: 2.975

Review 6.  The Physiological Mechanisms of the Sex-Based Difference in Outcomes of COVID19 Infection.

Authors:  Susan Wray; Sarah Arrowsmith
Journal:  Front Physiol       Date:  2021-02-09       Impact factor: 4.566

Review 7.  The Arcuate Nucleus of the Hypothalamus and Metabolic Regulation: An Emerging Role for Renin-Angiotensin Pathways.

Authors:  Darren Mehay; Yuval Silberman; Amy C Arnold
Journal:  Int J Mol Sci       Date:  2021-06-30       Impact factor: 5.923

Review 8.  The Vasoactive Mas Receptor in Essential Hypertension.

Authors:  Amalie L Povlsen; Daniela Grimm; Markus Wehland; Manfred Infanger; Marcus Krüger
Journal:  J Clin Med       Date:  2020-01-18       Impact factor: 4.241

9.  Angiotensin-(1-7) Receptor Mas Deficiency Does Not Exacerbate Cardiac Atrophy Following High-Level Spinal Cord Injury in Mice.

Authors:  Anne Järve; Fatimunnisa Qadri; Mihail Todiras; Shirley Schmolke; Natalia Alenina; Michael Bader
Journal:  Front Physiol       Date:  2020-03-12       Impact factor: 4.566

Review 10.  Renin-angiotensin-system inhibition in the context of corona virus disease-19: experimental evidence, observational studies, and clinical implications.

Authors:  Filippos Triposkiadis; Randall C Starling; Andrew Xanthopoulos; Javed Butler; Harisios Boudoulas
Journal:  Heart Fail Rev       Date:  2020-09-01       Impact factor: 4.214
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.